Dear Esteemed Participants,
The World Conference on Cancer Research and Novel Drug Development (WCCRDD-2027), scheduled for September 13-15, 2027, in Tokyo, Japan. will serve as a premier platform for oncologists, researchers, pharmaceutical experts, and healthcare professionals to explore the latest advancements in cancer treatment and drug discovery. The conference will cover a wide range of topics, including cancer biology, precision medicine, immunotherapy, targeted drug development, and emerging technologies such as AI-driven oncology and nanomedicine. Discussions will also focus on advancements in clinical trials, biomarker discovery, and innovative screening techniques to improve early detection and patient outcomes. Through keynote presentations, panel discussions, workshops, and networking sessions, the summit aims to foster interdisciplinary collaboration and accelerate breakthroughs in cancer therapeutics. By bringing together experts from academia, industry, and healthcare, WCCRDD-2027 will play a crucial role in shaping the future of oncology and revolutionizing cancer treatment strategies worldwide.
Welcome To WCCRDD-2027!
Registration:
Conference registration opens at 08:00 AM on first day of the conference, at the venue. The specific conference room will be listed in the final program. The registration desk will be open daily from 8 AM onwards. At the registration desk, attendees will receive their conference badge, folder, abstract book, and program. On-site coordinators will be available at the desk to assist with any inquiries. Lunch vouchers will be provided at the registration desk and must be handed to restaurant staff when claiming lunch.
Oral Presentation Guidelines:
Please be aware that minor schedule adjustments may occur. Presenters should be available in the meeting room from the conference start time on their presentation day. Plenary presentations: 45-50 minutes (including Q&A), Keynote: 30-35 minutes, Featured: 20-25 minutes. Please adhere to the allocated time. The official language of the conference is English. Presentations should be submitted in PDF or PPT format with clear, legible visuals. Submit presentation slides at least 15 days before the conference and bring a copy on a flash drive. Verify that your presentation is working properly before the session starts. The meeting room is equipped with a digital projector, screen, laptop, pointer, cordless mic, desktop mic, and basic sound system. Using personal laptops is discouraged unless absolutely necessary. Windows/PC users should ensure compatibi
lity with the MAC system used at the lectern.
Submit talks related to these topics
Understanding our evaluation criteria helps you craft a better proposal
How valuable is the content
Speaker's experience level
Relevance to the event themes
Each submission will receive at least 2 reviews from our review team
Monday, September 13, 2027
to Wednesday, September 15, 2027
Europe/London
Mitsui Garden Hotel Toyosu Premier, Tokyo, Japan, Tokyo
onlineAccepted presentation types
A 30-minute oral presentation for researchers, scientists, oncologists, academicians, and industry professionals to present their latest findings, innovative research, and advancements in cancer research and novel drug development, followed by a Q&A session Standard 30-minute presentation